What the weight loss injection actually does to your body

Both licensed injections slow gastric emptying, meaning food stays in your stomach longer and fullness arrives sooner and lasts longer after meals.
They act on appetite-regulating centres in the brain, reducing hunger signals — not just the sensation of being full, but the drive to eat in the first place.
Tirzepatide targets two receptors (GIP and GLP-1); semaglutide targets one (GLP-1), the dual action of tirzepatide is what makes it the only dual-agonist weight-loss medicine licensed in the UK.
Neither injection is a stimulant or fat-blocker: the mechanism is hormonal, working with the body's own signalling rather than forcing the issue.

The weight loss injection works by mimicking gut hormones that signal fullness and slow the rate at which your stomach empties. In plain terms: you feel satisfied on less food, cravings quieten, and your body's calorie intake falls — not through willpower, but through biology. These are prescription-only medicines, assessed individually by a prescriber before any treatment begins. There are two main injections licensed in the UK for weight management (tirzepatide (Mounjaro) and semaglutide (Wegovy)) and while they share this general mechanism, they act on slightly different receptors, which matters when your prescriber is deciding which suits you.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Inside the mechanism, and what it means for you day to day

The moment you inject: what's happening in the first few hours

Picture a Tuesday evening. You've taken your pen out of the fridge, cleaned the skin on your thigh, pressed the button and heard the click. Within minutes the medicine is absorbed into the tissue beneath the skin. You won't feel it working, there's no rush, no jolt. Over the next several hours, though, tirzepatide or semaglutide begins binding to receptors in the gut and the brain that are normally activated by the hormones GIP and GLP-1, released naturally after you eat.

The practical result: when your next meal comes around, the gastric-emptying signal is slowed. Food moves through your stomach at a reduced rate. You feel fuller faster and stay satisfied longer. The brain's appetite centres also receive a quieter hunger signal, so the background noise of wanting to eat (the mid-afternoon biscuit pull, the extra portion) gradually softens. This isn't suppression in the blunt sense of an appetite suppressant; it's closer to a recalibration of your body's own satiety machinery.

These medicines are injected once weekly because they have a long half-life in the body, maintaining consistent receptor activity rather than peaks and troughs. The full mechanism of the weight loss injection, including how the GIP and GLP-1 pathways differ, is worth reading if you want the detail behind the biology. The NHS patient information page for tirzepatide covers what to expect in accessible, verified terms.

What changes over weeks, and what the trial data actually showed

The hormonal signalling effect is fairly immediate, but meaningful weight change takes weeks of consistent lower calorie intake. Clinical trials give the clearest picture of scale. In the SURMOUNT-1 trial (2,539 adults with obesity, running for 72 weeks) participants on the highest tirzepatide dose achieved around 20–21% average body-weight reduction. Whether the weight loss injection works to that degree for any individual depends on adherence, diet, activity and clinical suitability, but the trial evidence is the strongest we have. Semaglutide's STEP 1 trial, similarly structured, showed around 15% average reduction at the 2.4mg maintenance dose over 68 weeks.

Day to day, people typically notice the appetite change before the scale moves. Portions shrink naturally. Foods that were hard to resist become easier to pass on, not because of discipline, but because the desire has genuinely reduced. That shift can feel unfamiliar at first. It also means nutrition matters more, not less: eating less but eating well (enough protein, enough fibre, adequate hydration) is what a prescriber or dietitian would encourage alongside treatment.

The titration schedule (starting at a low dose and increasing gradually) exists precisely because these hormonal changes also affect how quickly your stomach empties, and moving too fast produces the nausea and GI discomfort that some people experience. Starting low is not a delay; it's how the medicine is designed to be used safely. The SURMOUNT-1 paper in the New England Journal of Medicine details the full efficacy and safety data if you want to read primary evidence.

Side effects: the biology behind the discomfort

The same mechanism that produces weight loss explains most of the side effects. Slowing gastric emptying can cause nausea, particularly in the early weeks or after a dose increase. Diarrhoea, constipation, burping, and indigestion are all downstream of the same gut-signalling effect. For most people these are mild and settle within a couple of weeks as the body adjusts. They are not a sign something is wrong, they are the expected pharmacology doing its job at a new intensity.

There are rarer effects that warrant prompt attention. Severe, persistent stomach pain that radiates to the back (with or without vomiting) should be assessed urgently, as this can be a sign of pancreatitis. The MHRA highlighted acute pancreatitis as a known, infrequent but serious risk in a Drug Safety Update issued in January 2026; it's worth knowing about, without letting it overshadow the overall safety profile for suitable patients. Gallbladder symptoms, signs of dehydration from severe GI illness, and any allergic reaction also need prompt medical review.

Injection-site discomfort is usually minor and temporary. Whether the injection hurts is one of the questions our prescribers hear most often, in practice, the pen is designed so the needle is small and the mechanism does most of the work. Rotating sites between the abdomen, thigh and upper arm helps prevent local reactions. Any suspected side effect can be reported directly to the MHRA's Yellow Card scheme.

What it doesn't do, and why that matters

The injection doesn't burn fat directly, accelerate your metabolism in the stimulant sense, or work independently of what you eat. It creates the hormonal conditions in which eating less becomes easier, the rest is still down to the choices that become genuinely easier to make. It also doesn't continue working after you stop: the appetite effects reverse as the medicine clears your system, which is why ongoing clinical review and building sustainable habits alongside treatment matters.

It isn't suitable for everyone. Pregnancy, breastfeeding, and trying to conceive are contraindications; the medicines aren't licensed for under-18s; and certain conditions, including a history of medullary thyroid cancer or pancreatitis, require careful prescriber assessment. A prescriber considers your full picture, not just your BMI. If you'd like to explore whether treatment is appropriate for you, our free consultation is reviewed the same day by a named, GPhC-registered prescriber. Our weight loss treatment page sets out what's available and how the process works, including what arrives: a tracked DPD parcel, plain packaging, with the pen inside exactly as described.

Questions about different names for the same medicines, or the difference between the injections and the newer tablet, are covered in detail on the weight loss injection names page. For the cost side of things, the page on weight loss injection costs explains what private pricing typically covers and what to look for.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions